Genmab: GEN3014's Demise And Implications For The HexaBody Platform
Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...
Mirage News57m
CHLA Study Links Blood-Brain Barrier to Down Syndrome Disorder
A new research study led by Jonathan D. Santoro, MD , Director of the Neuroimmunology Program at Children's Hospital Los Angeles, shows evidence of ...